Case | Country | Age/sex | AFB test | Days to initiate NTM treatment from onset | Route of infection | History of topical GM | Peak cell count of effluent (/μL) | Antibiotics (duration) | Catheter removal | Complication | Prognosis | Ref |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Japan | 59/F | (−) | 18 | ESI, TI | (+) | 1700 | AZM (1 week) CAM (22 weeks) AMK (22 weeks) IPM/CS (23 weeks) | (+) | Abscess | HD | Case 1 |
2 | Japan | 67/M | (−) | 5 | ESI, TI | (+) | 480 | CAM (28 weeks) AMK (28 weeks) IPM/CS (6 weeks) MFLX (20 weeks) | (+) | Abscess/EPS | HD | Case 2 |
3 | Hong Kong | 39/F | N/A | N/A | ESI | (+) | N/A | AMK (8 weeks) CAM (28 weeks) MEPM (4 weeks) | (+) | Abscess | HD | [4] |
4 | Hong Kong | 45/M | N/A | N/A | ESI | (+) | N/A | AMK (4 weeks) MFLX (20 weeks) AZM (6 weeks) | (+) | (−) | Resuming PD | [4] |
5 | Taiwan | 44/F | (+) | 28 | ESI | (−) | 53,512 | CAM (165 days) AMK (68 days) MEPM (165 days) LVFX (111 days) | (+) | Abscess | Death | [5] |
6 | Taiwan | 58/F | (+) | 3 | ESI, TI | (−) | 286 | IPM/CS (70 days) AMK (50 days) CAM (234 days) CPFX (217 days) DOXY (180 days) | (+) | Abscess | HD | [5] |
7 | Singapore | 70/M | (−) | 12 | N/A | (−) | 993 | MEPM (N/A) CAM (4 weeks) AMK (4 weeks) | (+) | Abscess | Death | [6] |
8 | Singapore | 50/M | (−) | 9 | ESI | (−) | 1715 | CAM (12 weeks) CPFX (12 weeks) | (+) | (−) | HD | [6] |
9 | Singapore | 56/M | (−) | 10 | ESI, TI | (−) | 115 | CAM (12 weeks) AMK (6 weeks) | (+) | (−) | Death | [6] |
10 | Singapore | 60/F | (+) | 7 | ESI, TI | (−) | 146 | CAM (12 weeks) AMK (6 weeks) | (+) | (−) | Resuming PD | [6] |
11 | Japan | 51/F | (+) | 6 | ESI, TI | (−) | 1200 | CAM (7 weeks) CPFX (3 weeks) AMK (3 weeks) | (+) | Abscess | HD | [7] |
12 | Saudi Arabia | 60/F | (+) | 10 | ESI, TI | (−) | 180 | CAM (8 weeks) AMK (8 weeks) | (+) | (−) | HD | [8] |
13 | Saudi Arabia | 64/F | (+) | 6 | N/A | (−) | 214 | CAM (12 weeks) | (+) | (−) | HD | [8] |
14 | Australia | 49/M | N/A | N/A | N/A | N/A | N/A | CEZ (N/A) | (+) | EPS | Death | [9] |
15 | Australia | 40/F | N/A | N/A | N/A | N/A | N/A | AMK (N/A) Cefoxitin (N/A) | (+) | (−) | N/A | [9] |
16 | Australia | 65/M | N/A | N/A | N/A | N/A | N/A | Ticarcillin (N/A) VCM (N/A) GM (N/A) | (+) | (−) | N/A | [9] |
17 | The Netherlands | 73/F | N/A | 34 | ESI | N/A | N/A | TGC (N/A) CAM (N/A) IPM/CS (N/A) | (+) | (−) | Death | [10] |
18 | USA | 67/M | (+) | 7 | N/A | (−) | 1647 | AMK (12 weeks) CAM (12 weeks) | (+) | (−) | HD | [11] |